Steven Richvalsky, executive vice president and chief financial officer at Ann Arbor, Mich.-based Genomic Solutions, plans to stay with the company through the formal closing process of its pending merger with Harvard Bioscience, which was announced last week, but has no concrete plans to stay beyond that time. “From today on, I will be flexible in terms of the opportunities that may come before me,” Richvalsky said.
Prior to joining Genomic Solutions in 1997, Richvalsky served as senior manager of corporate financial analysis, planning, and reporting at the software company Comshare, and has also worked at US Robotics group. Richvalsky is a certified public accountant, and earned a BS degree in business administration from John Carroll University in Cleveland, Ohio.
Kathleen Murphy, vice president of corporate communications at Genomic Solutions, will be leaving the company in the next few weeks.
John Stuelpnagel, a co-founder of San Diego bead array company Illumina, has been promoted to senior vice president of operations. Co-founder Mark Chee, who came to Illumina from Affymetrix, where he was an inventor on several patents, has taken a new position as research fellow. David Barker is assuming Chee’s prior management role as vice president and chief scientific officer. In his new role, Chee will work with genomics initiatives such as the public haplotyping project and will research new applications for Illumina’s technology.